Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current therapeutic options for Kaposi's sarcoma.

D I Abrams1

  • 1University of California, San Francisco 94110, USA.

Oncology (Williston Park, N.Y.)
|June 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating cannabis into clinical cancer care.

Current oncology (Toronto, Ont.)·2016
Same author

Cannabis in cancer care.

Clinical pharmacology and therapeutics·2015
Same author

Cannabinoid-opioid interaction in chronic pain.

Clinical pharmacology and therapeutics·2011
Same author

Vaporization as a smokeless cannabis delivery system: a pilot study.

Clinical pharmacology and therapeutics·2007
Same author

Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial.

Neurology·2007
Same author

Associations between water-treatment methods and diarrhoea in HIV-positive individuals.

Epidemiology and infection·2002

Treatment options for acquired immune deficiency syndrome (AIDS)-related Kaposi

Area of Science:

  • Oncology
  • Immunology
  • Dermatology

Background:

  • Acquired immune deficiency syndrome (AIDS)-related Kaposi's sarcoma (KS) treatment options have seen minimal advancement over the last decade.
  • Research progress is hindered by the lack of a standardized KS staging system and uniform response criteria.
  • Understanding KS pathogenesis, including angiogenesis and growth factors, is crucial for future therapeutic development.

Purpose of the Study:

  • To review current treatment modalities for AIDS-related Kaposi's sarcoma.
  • To highlight challenges in KS research and identify areas for future therapeutic innovation.
  • To emphasize the need for improved survival outcomes beyond palliative care for AIDS-related KS.

Main Methods:

  • Review of existing literature on AIDS-related Kaposi's sarcoma treatments.

Related Experiment Videos

  • Discussion of current therapeutic options: radiation therapy, chemotherapy, and biologic response modifiers.
  • Exploration of potential improvements in drug delivery systems for chemotherapy.

    • Main Results:

    • Current treatment landscape for AIDS-related KS remains largely unchanged.
    • Existing therapies include radiation, chemotherapy, and biologic response modifiers.
    • Potential for improved chemotherapy efficacy and reduced side effects through advanced delivery systems.

    Conclusions:

    • There is a critical need to recommit research efforts towards improving survival rates for patients with AIDS-related KS.
    • Future therapies may benefit from a deeper understanding of KS pathogenesis, particularly angiogenesis.
    • Focus should shift from purely cosmetic or palliative treatments to enhancing patient survival.